Sepsis Solutions
Identify Life-Threatening Infections Faster
Syndromic testing from BioFire provides rapid pathogen identification, which can help healthcare providers optimize life-saving therapy sooner for patients with bloodstream infections.
Syndromic testing from BioFire provides rapid pathogen identification, which can help healthcare providers optimize life-saving therapy sooner for patients with bloodstream infections.
Using multiplex PCR technology, the BioFire System requires just one patient sample and two minutes of hands-on time to deliver results on causative pathogens and relevant antimicrobial resistance genes in about an hour.
One syndromic test on the BioFire System rapidly delivers accurate and comprehensive diagnostic results, maximizing the chances of identifying the cause of infection and helping physicians quickly provide optimal therapy.
The FDA-cleared BioFire BCID2 Panel identifies 43 clinically relevant targets directly from positive blood cultures to aid in the rapid diagnosis of bloodstream infections.
The BioFire BCID2 Panel’s newly expanded target menu simultaneously targets a comprehensive grouping of pathogens that cause sepsis, including gram-negative bacteria, gram-positive bacteria, and yeast. It also detects 10 antimicrobial resistance markers, including a mecA/C and MREJ assay to aid in the specific identification of MRSA.
To help improve sepsis patient management, bioMérieux offers a complete range of diagnostic solutions for every stage of bloodstream infection. These diagnostic platforms set a new standard in blood culture identification by providing increased speed, flexibility, and ease-of-use.
Learn to recognize the signs and symptoms of sepsis, understand the combined risks of antimicrobial resistance and bloodstream infection, stay up to date on COVID-19 impacts, and discover how syndromic infectious disease testing plays a role in rapidly and accurately diagnosing sepsis infections.
Sepsis is a life-threatening complication that occurs when the body’s extreme response to an infection triggers damage in vital organ systems.
Fast, accurate diagnostics are a key component of addressing the urgent threats of sepsis and antimicrobial resistance together.
Almost any infection can lead to sepsis, especially in at risk populations. In the respiratory tract, SARS-CoV-2 is a common viral cause of sepsis.
BioFire’s growing collection of online educational resources can help provide the tools and training you need to continue your success in the medical field.
Boost your knowledge of sepsis, the BioFire BCID Panel, and other relevant infectious disease topics with a variety of on-demand continuing education coursework—including CME courses developed by the Accreditation Council for Continuing Medical Education (ACCME)—and earn P.A.C.E.® credits.
P.A.C.E.® credits are widely recognized in the clinical laboratory profession and can be used to fulfill most continuing education requirements. BioFire Diagnostics is an approved provider of continuing education in the clinical laboratory sciences by the ASCLS P.A.C.E.® Program.
Are you ready to order the BioFire FilmArray System or want to request a free demo? Click below to take the next step towards faster results. Our team is ready to answer all of your questions.
Product availability varies by country. Consult your bioMérieux representative.